Skip to main content
. 2019 Jun 25;10:2782. doi: 10.1038/s41467-019-10669-0

Fig. 4.

Fig. 4

Identification of potential targets of FTO in melanoma. a Schematic summary for analysis of FTO target genes and number of genes identified. b Relative expression of FTO, PD-1 (PDCD1), CD274, and CD47 in Mel624 cells with or without FTO knockdown. c Distribution of m6A peaks across the length of mRNA. Region of 5-untranslated region (5′UTR) was binned into 10 segments, coding region (CDS) was binned into 50 segments, and 3-untranslated region (3′UTR) was binned into 40 segments, and the percentage of m6A peaks that fall within each bin was determined. d The proportion of m6A peak distribution in the indicated regions across the entire set of mRNA transcripts (top) and the appearance of new m6A peaks (unique peaks in shFTO), or loss of existing m6A peaks (unique peaks in shNC) after FTO knockdown (bottom). e Number of m6A-modified genes identified in m6A-seq in shNC and shFTO Mel624 cells. Common m6A genes contain at least one common m6A peak, while unique m6A genes contain no common m6A peaks. f Top consensus m6A motif identified by HOMER with m6A peaks in Mel624 cells with or without FTO knockdown. g qPCR analysis of mRNA levels of genes in Mel624 cells with shNC or shFTO. h Gene-specific m6A qPCR analysis of gene-specific m6A enrichment in Mel624 cells with shNC or shFTO. Data are shown as mean ± S.E. (n ≥ 3). *P < 0.05; **P < 0.01; ***P < 0.001; Student’s t-test